DefiniGEN, a provider of iPSC-derived products and disease modelling services, has announced that the company has earned ISO 9001: 2015 certification at its Cambridge UK facility. ISO certification confirms excellence in quality management standards and validates the company's dedication to upholding international standards for its customers. DefiniGEN, a provider of iPSC-derived products and disease modelling services, has announced that the company has earned ISO 9001: 2015 certification at its Cambridge UK facility. ISO certification confirms excellence in quality management standards and validates the company's dedication to upholding international standards for its customers.
DefiniGEN is an England-based biotechnology company that develops and commercializes human cells and tissue models for the treatment of pancreatic and intestinal diseases.